Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | FAIRDEAL HEALTH CARE PRIVATE LIMITED | 1 | ₹3,960 |
| 2 | Schedule 2 | JAINAM PHARMA (INDIA) PRIVATE LIMITED | 1 | - |
| 3 | Schedule 3 | FAIRDEAL HEALTH CARE PRIVATE LIMITED | 2 | ₹5,840 |
| 4 | Schedule 4 | FAIRDEAL HEALTH CARE PRIVATE LIMITED | 1 | ₹2,450 |
| 5 | Schedule 5 | FAIRDEAL HEALTH CARE PRIVATE LIMITED | 3 | ₹2,850 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
16 Jul 2025, 1:00 pmClosed
PARASAFE POWDER PACK OF 810 GM
TAB 12 SQ HDM SUBLINGUAL LYOPHILISATE
DICLOFENAC SODIUM SUPPOSITORY 100MG
SUCCINYLCHLOLINE CHLORIDE 50MG PER ML IN 2ML INJECTION
NEOSTIGMINE 0.5MG IN 01 ML INJECTION
EPHEDRINE HCL 30 MG PER ML INJECTION
7976676
GEM/2025/B/6353143
Two Packet Bid
PARASAFE POWDER PACK OF 810 GM
30 days
Raigad
Item wise evaluation
BOQ
6 documents required · 6 mandatory
2 yrs
₹31
₹1 L
20%
Exempted
16 Jul 2025
25 Jun 2025
16 Jul 2025
PARASAFE POWDER PACK OF 810 GM
TAB 12 SQ HDM SUBLINGUAL LYOPHILISATE
DICLOFENAC SODIUM SUPPOSITORY 100MG
SUCCINYLCHLOLINE CHLORIDE 50MG PER ML IN 2ML INJECTION
NEOSTIGMINE 0.5MG IN 01 ML INJECTION
EPHEDRINE HCL 30 MG PER ML INJECTION
PARASAFE POWDER
TAB 12 SQ-HDM SUBLINGUAL LYOPHILISATE
DICLOFENAC SODIUM SUPPOSITORY 100MG
SUCCINYLCHLOLINE CHLORIDE 50MG/ML
NEOSTIGMINE 0.5MG
EPHEDRINE HCL 30MG/ML INJ
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7976676.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
bbqr_parasafe_2025-06-17-14-09-37_9889badfd11e5419e064c73bed7d5422.pdf
BOQ
boq_item_sample_file_2025-06-17-14-09-37_941e4998b760544cdd95dd46eaa1099a.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .